In Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 No Comments Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Tech Weekly: Micron Rises on Latest Results, Trump Media Jumps on TAE Merger December 21, 2025 Editor’s Picks: Silver Price Keeps Running, Breaks All-time High Again December 21, 2025 Denison, Skyharbour Finalize Saskatchewan Uranium Joint Venture Deal December 20, 2025